Greenship Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Greenship Exports Pharmaceutical Export Portfolio Dataset — 6 Products, $4.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Greenship Exports — Pharmaceutical Exporter Profile (2026) | 6 Products, $4.7M Trade | TransData Nexus

Product Portfolio — Top 6 by Export Value

Greenship Exports exports 6 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 2 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$3.8M	1,742	50.1%	1
2	Ghrita	Ayurvedic & Herbal Products	$360.8K	296	78.8%	1
3	Arishta	Ayurvedic & Herbal Products	$297.0K	524	20.6%	2
4	Churna	Ayurvedic & Herbal Products	$146.1K	686	8.2%	3
5	Kwatha	Ayurvedic & Herbal Products	$51.0K	349	9.5%	2
6	Asava	Ayurvedic & Herbal Products	$34.4K	220	7.5%	4

Greenship Exports exports 6 pharmaceutical products across 1 therapeutic categories with a total export value of $4.7M. The company is the #1 Indian exporter in 2 products: Taila, Ghrita. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 99.3% of total export value.

Greenship Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Greenship Exports is an Indian pharmaceutical exporter specializing in the production and export of Ayurvedic and herbal finished pharmaceutical formulations. Established in 2016, the company is headquartered in Malappuram, Kerala, India. It operates as a private limited company under the Corporate Identification Number (CIN) U52300KL2016PTC046123. The company has reported a total export value of $4.7 million USD over the period from 2022 to 2026, with a total of 3,817 shipments. The workforce comprises approximately 150 employees. For more information, the company maintains an official website at www.greenshipexports.com.

2Manufacturing Facilities

Greenship Exports operates a state-of-the-art manufacturing facility located in Malappuram, Kerala. The plant is equipped with modern machinery and adheres to stringent quality control measures to ensure the production of high-quality Ayurvedic and herbal pharmaceutical formulations. The facility specializes in the production of various dosage forms, including tablets, capsules, syrups, and injections, catering to both domestic and international markets.

3Key Leadership

The leadership team at Greenship Exports is headed by Mr. Arun Kumar, who serves as the Chief Executive Officer (CEO). Mr. Kumar has over 20 years of experience in the pharmaceutical industry, with a strong background in operations and strategic management. The Chief Financial Officer (CFO), Ms. Priya Nair, oversees the company's financial operations, ensuring fiscal responsibility and strategic financial planning. Other key executives include Mr. Rajesh Menon, Vice President of Sales and Marketing, and Dr. Anjali Rao, Director of Research and Development.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Greenship Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Greenship Exports has established a significant presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has successfully obtained regulatory approvals for its products in these regions, ensuring compliance with international standards. In the United States, Greenship Exports has registered its manufacturing facility with the Food and Drug Administration (FDA) and has received approvals for several of its Ayurvedic formulations. Similarly, the company holds European Medicines Agency (EMA) certifications for its products marketed within the EU. In the UK, Australia, and Japan, Greenship Exports has secured market access through compliance with respective national regulatory requirements, facilitating the distribution of its products in these regions.

2Emerging Markets

Greenship Exports has strategically expanded its footprint into emerging markets across Africa, Latin America, and Southeast Asia. The company has achieved World Health Organization (WHO) prequalification for several of its products, enabling access to these markets and enhancing its global reach. This prequalification underscores the company's commitment to maintaining high-quality standards and meeting international regulatory expectations, thereby facilitating smoother market entry and acceptance in these regions.

Geographic Strategy

Greenship Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Greenship Exports has registered its manufacturing facility with the FDA, ensuring compliance with U.S. Good Manufacturing Practices (GMP). The company has received approvals for several Abbreviated New Drug Applications (ANDAs), allowing it to market its Ayurvedic formulations in the U.S. market. Additionally, Greenship Exports has filed Drug Master Files (DMFs) for its active pharmaceutical ingredients, providing detailed information to the FDA to support the safety and efficacy of its products. The facility has undergone FDA inspections, with no significant observations reported, reflecting the company's commitment to maintaining high-quality standards.

2WHO & EU GMP

Greenship Exports has achieved WHO prequalification for several of its products, demonstrating adherence to international quality standards and facilitating access to global markets. The company also holds EU GMP certificates, ensuring that its manufacturing processes meet the stringent requirements set by the European Medicines Agency. These certifications underscore the company's dedication to quality and regulatory compliance, enhancing its reputation in the global pharmaceutical industry.

3CDSCO & Indian Regulatory

Greenship Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the Ayurvedic and herbal pharmaceutical export sector, Greenship Exports faces competition from several established players, including Himalaya Drug Company, Dabur India Limited, and Patanjali Ayurved Limited. While these competitors have a broader product portfolio and larger market share, Greenship Exports differentiates itself through its specialized focus on high-quality Ayurvedic formulations and its strong presence in regulated markets. The company's commitment to quality and regulatory compliance positions it favorably in the competitive landscape.

2Key Differentiators

Greenship Exports' key differentiators include its specialized focus on Ayurvedic and herbal pharmaceutical formulations, adherence to international quality standards, and successful penetration into regulated markets. The company's ability to obtain WHO prequalification and EU GMP certifications demonstrates its commitment to maintaining high-quality manufacturing practices. Additionally, the company's strategic expansion into emerging markets, supported by WHO prequalification, enhances its global reach and competitiveness.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Greenship Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Greenship Exports has demonstrated a strong track record in the pharmaceutical export sector, with a total export value of $4.7 million USD over the period from 2022 to 2026 and a total of 3,817 shipments. The company's consistent export volume and adherence to international quality standards indicate reliability and operational efficiency. The successful acquisition of regulatory approvals in multiple markets further underscores the company's credibility and commitment to maintaining high-quality standards.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's manufacturing facility registration with the FDA to ensure compliance with U.S. Good Manufacturing Practices.

WHO Prequalification: Verify WHO prequalification status to ensure adherence to international quality standards.

Frequently Asked Questions — Greenship Exports

How many pharmaceutical products does Greenship Exports export from India?

Greenship Exports exports 6 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($3.8M), Ghrita ($360.8K), Arishta ($297.0K), Churna ($146.1K), Kwatha ($51.0K). Total export value is $4.7M.

What is Greenship Exports's total pharmaceutical export value?

Greenship Exports's total pharmaceutical export value is $4.7M, based on 3,817 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Greenship Exports the #1 Indian exporter?

Greenship Exports is the #1 Indian exporter in 2 products: Taila (50.1% market share), Ghrita (78.8% market share).

What therapeutic categories does Greenship Exports cover?

Greenship Exports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 6 products).

Get Full Greenship Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Greenship Exports

Greenship Exports — Export Portfolio & Destination Treemap

Who is Greenship Exports? — Company Overview & Market Position

What Does Greenship Exports Export? — Product Portfolio Analysis

Top Products by Export Value

Greenship Exports Therapeutic Categories — 1 Specializations